| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
From the Institute for Cellular and Molecular Biology,*
the Instituto de Ciências Biomédicas Abel
Salazar,
and the Hospital Geral de Santo
António,
Porto, Portugal
Familial amyloidotic polyneuropathy (FAP) is a neurodegenerative disorder characterized by extracellular deposition of transthyretin (TTR) amyloid fibrils, particularly in the peripheral nervous system. No systematic immunohistochemical data exists relating TTR deposition with FAP progression. We assessed nerves from FAP patients in different stages of disease progression (FAP 0 to FAP 3) for TTR deposition by immunohistochemistry, and for the presence of amyloid fibrils by Congo Red staining. The nature of the deposited material was further studied by electron microscopy. We observed that early in FAP (FAP 0), TTR is already deposited in an aggregated nonfibrillar form, negative by Congo Red staining. This suggested that in vivo, preamyloidogenic forms of TTR exist in the nerve, in a stage before fibril formation. Cytotoxicity of nonfibrillar TTR was assessed in nerves of different FAP stages by immunohistochemistry for macrophage colony-stimulating factor. FAP 0 patients already presented increased axonal expression of macrophage colony-stimulating factor that was maintained in all other stages, in sites related to TTR deposition. Toxicity of synthetic TTR fibrils formed in vitro at physiological pH was studied on a Schwannoma cell line by caspase-3 activation assays and showed that early aggregates but not mature fibrils are toxic to cells. Taken together, these results show that nonfibrillar cytotoxic deposits occur in early stages of FAP.
This article has been cited by other articles:
 |
|
 |
|
  E. Herczenik and M. F. B. G. Gebbink Molecular and cellular aspects of protein misfolding and disease FASEB J, July 1, 2008; 22(7): 2115 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Reixach, T. R. Foss, E. Santelli, J. Pascual, J. W. Kelly, and J. N. Buxbaum Human-Murine Transthyretin Heterotetramers Are Kinetically Stable and Non-amyloidogenic: A LESSON IN THE GENERATION OF TRANSGENIC MODELS OF DISEASES INVOLVING OLIGOMERIC PROTEINS J. Biol. Chem., January 25, 2008; 283(4): 2098 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stefani Generic Cell Dysfunction in Neurodegenerative Disorders: Role of Surfaces in Early Protein Misfolding, Aggregation, and Aggregate Cytotoxicity Neuroscientist, October 1, 2007; 13(5): 519 - 531. [Abstract] [PDF]
|
|
|
|
 |
|
 N. D. Hammer, J. C. Schmidt, and M. R. Chapman The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization PNAS, July 24, 2007; 104(30): 12494 - 12499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang and J. Robbins Heart Failure and Protein Quality Control Circ. Res., December 8, 2006; 99(12): 1315 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Dember Amyloidosis-Associated Kidney Disease J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3458 - 3471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-J. KIM and R. TAKAHASHI Role of Polyunsaturated Fatty Acids for Misfolding Protein Aggregations: Implication for Neurodegenerative Diseases Ann. N.Y. Acad. Sci., November 1, 2006; 1086(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Teixeira, F. Cerca, S. D. Santos, and M. J. Saraiva Endoplasmic Reticulum Stress Associated with Extracellular Aggregates: EVIDENCE FROM TRANSTHYRETIN DEPOSITION IN FAMILIAL AMYLOID POLYNEUROPATHY J. Biol. Chem., August 4, 2006; 281(31): 21998 - 22003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pieri, M. Bucciantini, D. Nosi, L. Formigli, J. Savistchenko, R. Melki, and M. Stefani The Yeast Prion Ure2p Native-like Assemblies Are Toxic to Mammalian Cells Regardless of Their Aggregation State J. Biol. Chem., June 2, 2006; 281(22): 15337 - 15344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Novitskaya, O. V. Bocharova, I. Bronstein, and I. V. Baskakov Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons J. Biol. Chem., May 12, 2006; 281(19): 13828 - 13836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Cardoso and M. J. Saraiva Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model FASEB J, February 1, 2006; 20(2): 234 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cecchi, S. Baglioni, C. Fiorillo, A. Pensalfini, G. Liguri, D. Nosi, S. Rigacci, M. Bucciantini, and M. Stefani Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates J. Cell Sci., August 1, 2005; 118(15): 3459 - 3470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lindgren, K. Sorgjerd, and P. Hammarstrom Detection and Characterization of Aggregates, Prefibrillar Amyloidogenic Oligomers, and Protofibrils Using Fluorescence Spectroscopy Biophys. J., June 1, 2005; 88(6): 4200 - 4212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Morais-de-Sa, P. J. B. Pereira, M. J. Saraiva, and A. M. Damas The Crystal Structure of Transthyretin in Complex with Diethylstilbestrol: A PROMISING TEMPLATE FOR THE DESIGN OF AMYLOID INHIBITORS J. Biol. Chem., December 17, 2004; 279(51): 53483 - 53490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bucciantini, G. Calloni, F. Chiti, L. Formigli, D. Nosi, C. M. Dobson, and M. Stefani Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity J. Biol. Chem., July 23, 2004; 279(30): 31374 - 31382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Koike, K. Misu, M. Sugiura, M. Iijima, K. Mori, M. Yamamoto, N. Hattori, E. Mukai, Y. Ando, S. Ikeda, et al. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy Neurology, July 13, 2004; 63(1): 129 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. MacRaild, C. R. Stewart, Y.-F. Mok, M. J. Gunzburg, M. A. Perugini, L. J. Lawrence, V. Tirtaatmadja, J. J. Cooper-White, and G. J. Howlett Non-fibrillar Components of Amyloid Deposits Mediate the Self-association and Tangling of Amyloid Fibrils J. Biol. Chem., May 14, 2004; 279(20): 21038 - 21045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Korenaga, X. Fu, Y. Xing, T. Matsusita, K. Kuramoto, S. Syumiya, K. Hasegawa, H. Naiki, M. Ueno, T. Ishihara, et al. Tissue Distribution, Biochemical Properties, and Transmission of Mouse Type A AApoAII Amyloid Fibrils Am. J. Pathol., May 1, 2004; 164(5): 1597 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Plakoutsi, N. Taddei, M. Stefani, and F. Chiti Aggregation of the Acylphosphatase from Sulfolobus solfataricus: THE FOLDED AND PARTIALLY UNFOLDED STATES CAN BOTH BE PRECURSORS FOR AMYLOID FORMATION J. Biol. Chem., April 2, 2004; 279(14): 14111 - 14119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Reixach, S. Deechongkit, X. Jiang, J. W. Kelly, and J. N. Buxbaum Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture PNAS, March 2, 2004; 101(9): 2817 - 2822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Merlini and V. Bellotti Molecular Mechanisms of Amyloidosis N. Engl. J. Med., August 7, 2003; 349(6): 583 - 596. [Full Text] [PDF]
|
|
|
|
|
|
I. CARDOSO, G. MERLINI, and M. J. SARAIVA 4'-iodo-4'-Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters FASEB J, May 1, 2003; 17(8): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Sousa, R. Fernandes, J. A. Palha, A. Taboada, P. Vieira, and M. J. Saraiva Evidence for Early Cytotoxic Aggregates in Transgenic Mice for Human Transthyretin Leu55Pro Am. J. Pathol., November 1, 2002; 161(5): 1935 - 1948. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
